Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies 2020 | World’s first off-the-shelf NK cellular immunotherapy

Troels Jordansen • 1 Sep 2020
Advanced Therapies 2020
Acute Myeloid Leukemia Leukemia oNKord®

Troels Jordansen, Glycostem Therapeutics, Oss, The Netherlands, discusses the development of the world’s first off-the-shelf NK cellular immunotherapy in acute myeloid leukemia patients and subsequent clinical trials involving oNKord® cellular therapy. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Troels Jordansen

1:03
4-year Horizon 2020 ITN-Marie Curie training network
Troels Jordansen • 1 Sep 2020

Related Videos

5:15
CD33 CRISPR/Cas9 gene-edited donor allograft in patients with AML at risk of relapse post-HSCT
John DiPersio • 21 Feb 2023
3:52
Outcomes of children and young adults with B-ALL following tisa-cel reinfusion
Kevin McNerney • 24 Feb 2023
3:19
Safety and efficacy of LV20.19 CAR-T therapy in Richter's transformation and R/R MCL
Nirav Shah • 15 Feb 2023
3:48
Preliminary results from Phase I study of CD123 CAR-T therapy in pediatric R/R AML
Swati Naik • 20 Feb 2023
The content of VJRegenMed is intended for healthcare professionals